Clinical Performance of Passeo-18 Lux Confirmed: High Target Lesion Patency Despite High-Risk Patient Group

06.03.2014 - BIOTRONIK, a leading manufacturer of cardiovascular devices, today announced positive six-month results from the BIOLUX P-II study. The study investigated the performance of the Passeo-18 Lux Drug Releasing Balloon (DRB) in the treatment of vascular occlusions of the lower extremities ...